⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Nivolumab in Recurrent or Metastatic Salivary Gland Carcinoma of the Head and Neck

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Nivolumab in Recurrent or Metastatic Salivary Gland Carcinoma of the Head and Neck

Official Title: A Phase II, Multicenter, Non Randomized, Open Label Study of Nivolumab In Recurrent and/or Metastatic Salivary Gland Carcinoma of the Head and Neck

Study ID: NCT03132038

Interventions

Nivolumab

Study Description

Brief Summary: INDICATION: Patients with recurrent and/or metastatic salivary glands carcinoma who have progressed during the 6 months period before entering the study and who are eligible for nivolumab monotherapy.

Detailed Description: METHODOLOGY: The present study is a multicenter, open-label, non-controlled, phase II study in patients who are suffering from recurrent and/or metastatic Salivary Glands Carcinoma, who have progressed during the 6 months period before entering the study and who are eligible for nivolumab monotherapy. All eligible patients will receive nivolumab treatment for a maximum of 12 cycles of treatment. 92 eligible patients will be dosed with nivolumab intravenously over 60 minutes (± 5 minutes) at 3 mg/kg every two weeks. Each 28-day dosing period will constitute a cycle.

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

CHU Bordeaux, Bordeaux, , France

Centre Georges François Leclerc, Dijon, , France

Centre Léon Bérard, Lyon, , France

ICM Val d'Aurelle, Montpellier, , France

Centre Antoine Lacassagne, Nice, , France

Institut Curie, Paris, , France

Institut Curie Saint Cloud, Saint Cloud, , France

Centre René Gauducheau, Saint-Herblain, , France

Centre Paul Strauss, Strasbourg, , France

Institut de cancérologie Alexis Vautrin, Vandoeuvre les Nancy, , France

Gustave Roussy, Villejuif, , France

Contact Details

Name: Jérôme FAYETTE, MD

Affiliation: Léon Bérard Center

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: